Avoid The DOJ - FCPA Violations - Foreign Corrupt Practices Act

Image via Wikipedia

I never heard about the FCPA (Foreign Corrupt Practices Act) until reading about it today. Wikipedia says FCPA addresses accounting transparency requirements under the Securities Exchange Act of 1934 and another concerning bribery of foreign officials.

Anyways, FDANews reports that the Department of Justice’s (DOJ) FCPA and healthcare fraud units are beginning to work together to investigate FCPA violations in the device and pharmaceutical industries. The DOJ has more information about FCPA on their website.

Here's why you need to care. The DOJ wants to aggressively enforce and investigate violations of the FCPA, targeting pharmaceutical and medical device companies as well as their individual executives and board members; this leaves them open to potentially massive legal and financial liabilities.

Additional Resources:
Bribery Abroad: Lessons from the Foreign Corrupt Practices Act

Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/

Related articles by Zemanta

• Breuer Sends FCPA Warning to Big Pharma (and its Executives) (blogs.wsj.com)
• Understanding China FCPA Risks. Who Is A Foreign Official? (chinalawblog.com)
• Now It's Personal: The DOJ Targets Individuals In Prosecuting Bribery (blogs.wsj.com)